1,135
+0.89%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About JTEC
Its shares trade on Tokyo Stock Exchange under the ticker 3446.T. It has been listed since 28 February 2018. In the fiscal year to 30 June 2026, it reported revenue of ¥1.96bn and net income of ¥58.7m. At that date it held total assets of ¥3.61bn and shareholders' equity of ¥2.85bn.
JTEC Corp. engages in the development, designing, manufacturing and sale of various automation systems. The company is headquartered in Ibaraki-Shi, Osaka-Fu. The company went IPO on 2018-02-28. The firm operates through two business segments. The main products of the Optical segment are X-ray nano-collecting mirrors for synchrotron radiation and X-ray free electron laser facilities. This segment is engaged in the manufacture and sale of special mirrors focusing on X-ray nano-collecting mirrors used for advanced analyzers for a wide range of research including basic research and industrial applications. The main products of the Life Science and Equipment Development segment are various automatic cell culture devices and other automation devices. This segment develops, sells various automatic cell culture devices. In addition to medical and biotechnology fields, it develops, manufactures and sells outsourced products and proprietary products to research institutes and companies in various fields.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 28 Feb 2018
- Employees
- 64
- Website
- j-tec.co.jp ↗
Leadership
Pay as last reported
- Mr. Takashi TsumuraPresident, Chairman of Subsidiary, Representative Director, since 1993
- Mr. Masahiko KanaokaDirector of Sales, Director, since 2020
- Mr. Tetsuya HiyaManager of Audit Office, Director, since 2022
- Mr. Isahiro HasegawaIndependent Director
- Mr. Nozomu KawasakiIndependent Director
- Mr. Yoshio MatsumiIndependent Director
- Mr. Masanori TsujiokaIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- JTEC Corp has a focused product portfolio in specialized automation systems for health care.
- The company operates with a small team of 64 employees, indicating operational efficiency.
- JTEC Corp has a clear market presence in niche segments like X-ray nano-collecting mirrors and cell culture devices.
Weaknesses
- The company's small size with only 64 employees may limit scalability and resource availability.
- JTEC Corp's operations are concentrated in specific segments, increasing vulnerability to market shifts.
- The company's IPO date is 2018, suggesting limited market history and potential investor skepticism.
Opportunities
- Growing demand for advanced automation systems in health care could expand JTEC Corp's market reach.
- Potential for expanding into new applications for X-ray nano-collecting mirrors beyond current research uses.
- Increasing collaboration opportunities with research institutes and biotechnology companies.
Threats
- Competition from larger firms in the health care automation sector may challenge JTEC Corp's market position.
- Economic downturns could reduce funding for research and development in health care.
- Reliance on specific segments like X-ray mirrors and cell culture devices exposes the company to industry-specific risks.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.